HUSSMAN STRATEGIC ADVISORS, INC. – Catalyst Pharmaceuticals, Inc. Transaction History
HUSSMAN STRATEGIC ADVISORS, INC. portfolio value:
$795,000
portfolio value
HUSSMAN STRATEGIC ADVISORS, INC. quarter portfolio value change:
+83.02%
quarter
Catalyst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -52.31% | -68K shares | -116K | $12.83 | 62K |
| Q2 2022 | share | Increase | +91.18% | 62K shares | 347K | $7.01 | 130K |
| Q1 2022 | share | 0.00% | 0 shares | 104K | $8.29 | 68K | |
| Q4 2021 | share | Decrease | -45.16% | -56K shares | -197K | $6.89 | 68K |
| Q3 2021 | share | 0.00% | 0 shares | -56K | $5.3 | 124K | |
| Q2 2021 | share | Increase | 0.00% | 124K shares | 713K | $5.75 | 124K |